HANNAH ALISON L.

CIK 00016456003 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001645600

Recent Transactions

50 trades

Exercise/Conversion
NEOGENOMICS INC$NEO
Restricted Stock Unit
2025-06-01−12,254→ 0 total
Award
NEOGENOMICS INC$NEO
Common Stock
2025-06-01+12,254→ 131,023 total
Award
NEOGENOMICS INC$NEO
Restricted Stock Unit
2025-06-01+23,077→ 23,077 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2025-06-01+12,254→ 131,023 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2025-06-01+16,107→ 16,107 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2025-05-23+3,000→ 3,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2025-05-23+2,500→ 10,625 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Restricted Stock Unit
2024-08-10−11,336→ 0 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2024-08-10+11,336→ 118,769 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2024-06-01+8,672→ 8,672 total
Award
NEOGENOMICS INC$NEO
Restricted Stock Unit
2024-06-01+12,254→ 12,254 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2024-05-25+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2024-05-25+25,000→ 81,250 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2023-08-10+8,353→ 8,353 total
Award
NEOGENOMICS INC$NEO
Restricted Stock Unit
2023-08-10+11,336→ 11,336 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2023-05-26+25,000→ 56,250 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2023-05-26+30,000→ 30,000 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-07-20$1.42/sh−5,602→ 31,898 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-07-19+15,000→ 37,500 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2022-06-10+13,882→ 13,882 total
Award
NEOGENOMICS INC$NEO
Common Stock
2022-06-10+15,556→ 107,433 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2022-05-20+30,000→ 30,000 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2022-05-20+25,000→ 31,250 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2022-02-02+135,000→ 135,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Common Stock
2022-02-02+22,500→ 22,500 total
Award
CytomX Therapeutics, Inc.$CTMX
Performance Stock Units (PSUs)
2021-10-24+30,000→ 30,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2021-10-24+40,000→ 40,000 total
Award
NEOGENOMICS INC$NEO
Common Stock
2021-06-02+3,081→ 91,877 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2021-06-02+3,714→ 3,714 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2021-05-19+7,500→ 7,500 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Common Stock
2021-05-19+6,250→ 6,250 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2021-05-14+80,000→ 80,000 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (right to buy)
2021-02-26+175,000→ 175,000 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2020-08-06$7.27/sh+10,000→ 88,796 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2020-08-06−10,000→ 0 total
Award
NEOGENOMICS INC$NEO
Stock Options (Right to Buy)
2020-05-28+3,448→ 3,448 total
Award
NEOGENOMICS INC$NEO
Common Stock
2020-05-28+2,698→ 78,796 total
Award
CytomX Therapeutics, Inc.$CTMX
Stock Option (Right to Buy)
2020-02-03+250,000→ 250,000 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2019-09-09$6.66/sh+3,333→ 67,765 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2019-09-09$9.11/sh−8,333→ 0 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2019-09-09$9.11/sh+8,333→ 76,098 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2019-09-09$6.66/sh−3,333→ 0 total
Award
NEOGENOMICS INC$NEO
Stock Options (Right to Buy)
2019-06-06+4,269→ 4,269 total
Award
NEOGENOMICS INC$NEO
Common Stock
2019-06-06+3,419→ 64,432 total
Award
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2018-06-01+3,017→ 3,017 total
Award
NEOGENOMICS INC$NEO
Common Stock
2018-06-01+15,564→ 61,013 total
Exercise of In-Money
NEOGENOMICS INC$NEO
Stock Option (Right to Buy)
2017-08-09$6.66/sh−6,667→ 3,333 total
Exercise/Conversion
NEOGENOMICS INC$NEO
Common Stock
2017-08-09$6.66/sh+6,667→ 45,449 total
Purchase
NEOGENOMICS INC$NEO
Common Stock
2017-07-27$9.19/sh+20,000→ 38,782 total
Conversion
NEOGENOMICS INC$NEO
Restricted Stock
2017-05-30−5,072→ 0 total

Companies

Recent Filings

Address

C/O RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov